The Portuguese generic medicines market: A policy analysis

Pharmacy Practice

Volumn 7, Issue 2, 2009, Pages 74-80

  Simoens, Steven ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Drug costs; Drugs, generic; Portugal; Reimbursement, incentive

Indexed keywords

GENERIC DRUG;

ARTICLE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; DRUG DISTRIBUTION; DRUG MARKETING; HEALTH CARE COST; HEALTH CARE POLICY; PATENT; PHARMACY; PORTUGAL; PROSPECTIVE PRICING; REIMBURSEMENT; SUBSTITUTION THERAPY;

EID: 70349199889     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.4321/S1886-36552009000200002     Document Type: Article

References (18)

1. Organisation for Economic Co-operation and Development (OECD). Health at a glance 2007: OECD indicators. Paris; OECD, 2007.
2. Directive 2004/27/EC of the European Parliament and of the Council of 31st March 2004 amending Directive 2001/83/EC on the Community code relating to medicinal products for human use. Official J EU. L 136/34-57.
3. European Generic Medicines Association. Basic notions of generics. Brussels; European Generic Medicines Association, 2008.
4. Simoens S, De Coster S. Sustaining generic medicines markets in Europe. J Generic Med. 2006;3:257-268.
5. IMS Health. Midas database. IMS Health; London, 2004.
6. Haas JS, Phillips KA, Gerstenberger EP, Seger AC, Potential savings from substituting generic drugs for brand-name drugs: medical expenditure panel survey, 1997-2000. Ann Intern Med. 2005;142(11):891-897.
7. Cox E, Behm A, Mager D, Miller S. Generic drug usage report. St. Louis; Express Scripts, 2004. Available at: http://www.express-scripts.com. Accessed September 17, 2008.
8. INFARMED. Market data. Lisbon; INFARMED, 2008. Available at: http://www.infarmed.pt/portal/page/portal/INFARMED (Accessed September 16, 2008).
9. European Generic Medicines Association. 2005 market review. The European generic pharmaceutical markets: price and reimbursement systems. Brussels; European Generic Medicines Association, 2005.
10. Directive 1989/105/EEC of 21st December 1988 relating to the transparency of measures regulating the pricing of medicinal products for human use and their inclusion in the scope of national health insurance systems. Official J EU. L 40/8-11.
11. European Generic Medicines Association. 2007 market review. The European generic pharmaceutical markets: price and reimbursement systems. Brussels; European Generic Medicines Association, 2007.
12. Barros PP, de Almeida Simoes J. Portugal: health system review. Health Systems in Transition. 2007;9:1-140.
13. Portela C, Pinto M. Reference pricing as a competition trigger on the Portuguese pharmaceutical market. Oral presentation at the 9th Conference of the Portuguese Association of Health Economics. Coimbra; November 22, 2005.
14. Pinto CG, Teixeira I. Pricing and reimbursement of pharmaceuticals in Portugal. Eur J Health Econ. 2002;3:267-270.
15. INFARMED. Estudo de Opinião sobre Medicamentos Genéricos (Study of the opinion about generic medicines). Lisbon; INFARMED, 2006. Available at: http://www.infarmed.pt/portal/page/portal/INFARMED (Accessed January 28, 2009).
16. INFARMED. Newsletter no. 19. Lisbon; INFARMED, 2006. Available at: http://www.infarmed.pt/infarmed_noticias/infarmed_noticias_01_02_2006.pdf (Accessed September 19, 2008).
17. Figueiras MJ, Marcelino D, Cortes MA. People's views on the level of agreement of generic medicines for different illnesses. Pharm World Sci. 2008;30(5):590-594.
18. Kanavos P, Taylor D. Pharmacy discounts on generic medicines in France: Is there room for further efficiency savings? Curr Med Res Opin 2007;23(10):2467-2476.